Fennec Pharmaceuticals
FENC
30 hedge funds and large institutions have $49.9M invested in Fennec Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 8 closing their positions.
57% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 7
23% more call options, than puts
Call options by funds: $194K | Put options by funds: $158K
1.16% less ownership
Funds ownership: 44.79% → 43.63% (-1.2%)
6% less funds holding
Funds holding: 32 → 30 (-2)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
54% less capital invested
Capital invested by funds: $110M → $49.9M (-$59.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
DG Capital Management
New York
|
+$4.03M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$798K |
| 3 |
TS
Tamar Securities
Woodland Hills,
California
|
+$398K |
| 4 |
WANY
Wealthspire Advisors (New York)
New York
|
+$186K |
| 5 |
HFA
Harbert Fund Advisors
Birmingham,
Alabama
|
+$112K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
-$3.5M |
| 2 |
6CM
683 Capital Management
New York
|
-$2.98M |
| 3 |
E
Ergoteles
New York
|
-$861K |
| 4 |
HF
HRT Financial
New York
|
-$526K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$298K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TWC
26
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $2.5K | +$4.13K | +555 | New |
|
27
BNP Paribas Financial Markets
Paris,
France
| $1.02K | -$179 | -24 | -9% |
|
|
E
28
Ergoteles
New York
| – | -$861K | -91,434 | Closed |
|
|
HF
29
HRT Financial
New York
| – | -$526K | -55,935 | Closed |
|
|
30
Russell Investments Group
London,
United Kingdom
| – | -$298K | -31,728 | Closed |
|
31
Belvedere Trading
Chicago,
Illinois
| – | -$155K | -17,790 | Closed |
|
|
PPA
32
Parametric Portfolio Associates
Seattle,
Washington
| – | -$104K | -10,994 | Closed |
|
33
Barclays
London,
United Kingdom
| – | -$25K | -2,648 | Closed |
|
34
Group One Trading
Chicago,
Illinois
| – | -$11.9K | -1,600 | Closed |
|
35
Wells Fargo
San Francisco,
California
| – | -$13K | -1,400 | Closed |
|
36
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$573 | -77 | -82% |
|
37
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | +$231 | +31 | +135% |
|
38
JP Morgan Chase
New York
| – | +$521 | +70 | New |
|
FENC Hedge Fund Activity: Q4 2021 in Review
30 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Fennec Pharmaceuticals (FENC) for Q4 2021, worth a combined $49.9M — down 54% from $110M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of FENC and 7 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 11 added.
The largest buyer was DG Capital Management, adding an estimated $4.03M. The largest seller was Avoro Capital Advisors, cutting an estimated $3.5M.
- 30 institutional investors held Fennec Pharmaceuticals (FENC) as of Q4 2021, down from 32 in Q3 2021.
- Funds reported $49.9M of Fennec Pharmaceuticals stock for Q4 2021, down 54% quarter-over-quarter.
- 7 funds opened new Fennec Pharmaceuticals positions in Q4 2021 and 8 closed out, a net change of -1 holder.
- The largest Fennec Pharmaceuticals buyer in Q4 2021 was DG Capital Management, an estimated $4.03M added.
- The largest Fennec Pharmaceuticals seller in Q4 2021 was Avoro Capital Advisors, an estimated $3.5M sold.
Based on aggregated 13F filings for Q4 2021.